- 期刊
Plasma Antimicrobial Peptide LL-37 Level Is Inversely Associated with HDL Cholesterol Level in Patients with Type 2 Diabetes Mellitus
延伸閱讀
- Hirao, K., Maeda, H., Shirabe, S. I., Yamamoto, R., Hirao, T., Hirao, S., Yamauchi, M., & Arai, K. (2012). Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA_(1c) Levels in Japanese Patients with Type 2 Diabetes Mellitus. Japanese Clinical Medicine, (), 1-7. https://doi.org/10.4137/JCM.S8571
- Wang, P. C., Hsu, C. S., Lin, H. H. H., & Wang, C. C. (2010). High-Density Lipoprotein Cholesterol Negatively Associated with Nonalcoholic Fatty Liver Disease in Non-Diabetic and Normal Weight Adults. 臺灣消化醫學雜誌, 27(4), 396-402. https://doi.org/10.6557/GJT.201012_27(4).0001
- Huri, H. Z., Selamat, N., & Vethakkan, S. R. (2014). Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study. International Journal of Endocrinology, 2014(), 657-663-070. https://doi.org/10.1155/2014/367564
- Qu, H., Deng, H., & Hu, Z. (2013). Plasma Progranulin Concentrations Are Increased in Patients with Type 2 Diabetes and Obesity and Correlated with Insulin Resistance. Mediators of Inflammation, 2013(), 54-59-105. https://doi.org/10.1155/2013/360190
- Chuang, W. C., Sun, C. C., Chang, W. C., Tsai, Y. H., Lin, Y. S., Wang, M. C., & Chu, C. H. (2016). Comparing the Effects between Atorvastatin 40 mg and Ezetimibe/Simvastatin 10/20 mg on Lipoprotein Parameters and Inflammatory Markers among Patients with Type 2 Diabetes Mellitus and Hyperlipidemia. Formosan Journal of Endocrinology and Metabolism, 7(1), 18-23. https://doi.org/10.6856/FJEM.201606_7(1).0003